With the objective of developing its production capacities under GMP environment, associated with pharmaceutical 3D printing technology, MB Therapeutics is delighted to announce the joining of Damien STEFANELLI to its leadership team.

Expertise in pharmaceutical operational excellence

With over 20 years of experience in the pharmaceutical industry (Ipsen, MedinCell, Skyepharma…), Damien brings his expertise in Lean Six Sigma, international project management, and pharmaceutical quality.

He has held various strategic positions, such as international project manager, quality assurance and quality control manager, quality auditor, batch releaser, as well as qualification/validation, development, scale-up, and manufacturing transfer manager at sites inspected by the US FDA, the ANSM and the ANVISA.

Alongside his operational responsibilities, Damien is also a trainer for CEFIRA and the Faculty of Pharmacy of Montpellier, and acts as an expert in Quality by Design, as a member of the GIC A3P QbD.

Thanks to his comprehensive experience and sharp vision of technical and regulatory constraints, his skills are perfectly aligned with the ambitions of MB Therapeutics.

A mission to accomplish

Joining the MB Therapeutics team is first and foremost an extremely inspiring and rewarding human adventure, with a common mission to put innovation and operational excellence at the service of patients. I would like to thank Stéphane (CEO) and Ian (CTO), the 2 founders of the start-up, for their trust.

Damien Stefanelli

By integrating Damien into the executive team and the steering committee, MB Therapeutics asserts its ambition to offer pharmaceutical inks manufactured in its own GMP-certified pharmaceutical establishment.

Revolutionizing personalized medicine through cutting-edge technology

The recruitment of Damien STEFANELLI as Chief Operating Officer (COO) strengthens MB Therapeutics' commitment to the production of personalized medicines by pharmaceutical 3D printing.

With his international experience, his Lean Six Sigma project management, and his human qualities, Damien joins a strategic position at MB Therapeutics which will enable him to leverage his expertise and network for the company's mission: to revolutionize personalized medicine through cutting-edge technology.